000			02139cam a22003497 4500
001			w23662
003			NBER
005			20211020104837.0
006			m o d
007			cr cnu||||||||
008			210910s2017 mau fo 000 0 eng d
100	1		_aBairoliya, Neha.
245	1	0	_aConsumer Learning and the Entry of Generic Pharmaceuticals / _cNeha Bairoliya, Pinar Karaca-Mandic, Jeffrey S. McCullough, Amil Petrin.
260			_aCambridge, Mass. _bNational Bureau of Economic Research _c2017.
300			_a1 online resource: _billustrations (black and white);
490	1		_aNBER working paper series _vno. w23662
500			_aAugust 2017.
520	3		_aGeneric pharmaceuticals provide low-cost access to treatment. Despite their chemical equivalence to branded products, many mechanisms may hinder generic substitution. Consumers may be unaware of their equivalence. Firms may influence consumers through advertising or product line extensions. We estimate a structural model of pharmaceutical demand where consumers learn about stochastic match qualities with specific drugs. Naïve models, without consumer heterogeneity and learning, grossly underestimate demand elasticities. Consumer bias against generics critically depends on experience. Advertising and line extensions yield modest increases in branded market shares. These effects are dominated by consumers' initial perception bias against generics.
530			_aHardcopy version available to institutional subscribers
538			_aSystem requirements: Adobe [Acrobat] Reader required for PDF files.
538			_aMode of access: World Wide Web.
588	0		_aPrint version record
690		7	_aI1 - Health _2Journal of Economic Literature class.
700	1		_aKaraca-Mandic, Pinar.
700	1		_aMcCullough, Jeffrey S.
700	1		_aPetrin, Amil. _918478
710	2		_aNational Bureau of Economic Research.
830		0	_aWorking Paper Series (National Bureau of Economic Research) _vno. w23662.
856	4	0	_uhttps://www.nber.org/papers/w23662
856			_yAcceso en línea al DOI _uhttp://dx.doi.org/10.3386/w23662
942			_2ddc _cW-PAPER
999			_c324460 _d283022